OMIC Digest Archives 2022

OMIC Digest: Vol. 32 | No. 1 | 2022

Feature: Giant Cell Arteritis: Delayed diagnosis and treatment
Eye on OMIC: Board changes and a new Chair announced for 2023
Policy Issues: Liability and coverage for patient falls
Closed Claim Study: Failure to diagnose Giant Cell Arteritis results in settlement
Risk Management Remedies: What’s in your toolbox?
< click to view or download

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Leader in the industry.

A-rated by AM Best, OMIC is consistently ranked among the top malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined, operating, and surplus ratios, the most relevant financial measurements for an insurance carrier.